Q&A

Chair(s)

• 

  Deepika S. Darbari, MD (she/her/hers)

  Division of Hematology
  Center for Cancer and Blood Disorders, Children's National Hospital
  George Washington University School of Medicine
  Washington , District of Columbia, United States

Speaker(s)

• 

  Michelle Davis, MSPH PhD (she/her/hers)

  Health Policy Executive
  U.S. Department of Health and Human Services
  New York, New York, United States
• 

  Mary Hulihan, DrPH

  Health Scientist
  CDC/NCBDDD/DBD
  Atlanta, Georgia, United States
• 

  Payal C. Desai, MD (she/her/hers)

  Director, Sickle Cell Enterprise/ Associate professor
  Levine Cancer Institute
  Levine Cancer Institute
  Charlotte, North Carolina, United States
• 

  Mandy S. David, MPH, PA-C

  Senior Public Health Analyst for the Sickle Cell Disease Programs
  Health Resources and Services Administration
  Rockville, Maryland, United States
• 

  Dora Hughes, MD, MPH (she/her/hers)

  Chief Medical Officer, CMS Innovation Center
  Centers for Medicare & Medicaid Services
  Baltimore, Maryland, United States
• 

  Patricia Oneal, MD (she/her/hers)

  Medical Officer
  Food and Drug Administration
  Silver Spring, Maryland, United States
• 

  Golda Houndoh, MSc (she/her/hers)

  Program Associate
  PCORI
  Washington, District of Columbia, United States